HomeCompareNH vs XYLD

NH vs XYLD: Dividend Comparison 2026

NH yields 148.15% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NH wins by $23.43M in total portfolio value
10 years
NH
NH
● Live price
148.15%
Share price
$1.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.46M
Annual income
$10,076,148.54
Full NH calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — NH vs XYLD

📍 NH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NH + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NH pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NH
Annual income on $10K today (after 15% tax)
$12,592.59/yr
After 10yr DRIP, annual income (after tax)
$8,564,726.26/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, NH beats the other by $8,561,990.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NH + XYLD for your $10,000?

NH: 50%XYLD: 50%
100% XYLD50/50100% NH
Portfolio after 10yr
$11.74M
Annual income
$5,039,683.78/yr
Blended yield
42.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NH right now

NH
Analyst Ratings
6
Buy
Consensus: Buy
Altman Z
-13.1
Piotroski
3/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NH buys
0
XYLD buys
0
No recent congressional trades found for NH or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHXYLD
Forward yield148.15%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$23.46M$25.3K
Annual income after 10y$10,076,148.54$3,219.02
Total dividends collected$21.69M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: NH vs XYLD ($10,000, DRIP)

YearNH PortfolioNH Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$25,515$14,814.81$10,818$1,098.39+$14.7KNH
2$62,628$35,326.85$11,738$1,222.51+$50.9KNH
3$148,051$81,039.20$12,774$1,364.64+$135.3KNH
4$337,457$179,042.34$13,944$1,527.86+$323.5KNH
5$742,477$381,398.70$15,270$1,715.87+$727.2KNH
6$1,578,712$784,260.93$16,775$1,933.09+$1.56MNH
7$3,247,684$1,558,462.68$18,490$2,184.87+$3.23MNH
8$6,471,310$2,996,288.20$20,450$2,477.63+$6.45MNH
9$12,504,097$5,579,794.89$22,697$2,819.19+$12.48MNH
10$23,455,532$10,076,148.54$25,280$3,219.02+$23.43MNH

NH vs XYLD: Complete Analysis 2026

NHStock

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Full NH Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this NH vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NH vs SCHDNH vs JEPINH vs ONH vs KONH vs MAINNH vs QYLDNH vs JEPQNH vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.